28.7% Fat Loss in 48 Weeks: Vietnam's GLP-1 Reality in 2026
Phase 2 trials of retatrutide hit 28.7% average body weight reduction over 48 weeks, the highest number ever recorded for a weight loss compound. It's the GLP-1 nobody can buy at a Vietnamese pharmacy, because it isn't FDA-approved yet. So Vietnam's expat and biohacker scene imports it research-grade, alongside the three other GLP-1s that matter here: tirzepatide (22.5%, available as branded Mounjaro at FV and Vinmec), semaglutide (14.9%, intermittent Ozempic in District 1 and District 7 pharmacies), and cagrilintide (10%+ standalone, used mostly for stacking).
For expats and locals serious about weight loss, the research-grade route has become the default. It's more affordable, more reliable, and unlocks compounds that won't be approved in Vietnam for years. But the path requires homework: verifying COAs, understanding reconstitution, and choosing between single-agonist (semaglutide), dual-agonist (tirzepatide), and triple-agonist (retatrutide) compounds. This page compares the four most relevant GLP-1 peptides for the Vietnam market and helps you pick.
Comparison Table
| Peptide | Avg Weight Loss | FDA Status | Vietnam Pharmacy | Research Cost/Month | Best For |
|---|---|---|---|---|---|
| ★RetatrutideWeight loss guide → | 28.7% | Phase 3 | Not available | ₫4–6M | Maximum weight loss |
| TirzepatideWeight loss guide → | 22.5% | FDA Approved | Mounjaro at hospitals | ₫2.5–4M | Balance + availability |
| SemaglutideWeight loss guide → | 15% | FDA Approved | Ozempic intermittent | ₫1.5–2.5M | Proven + affordable |
| Cagrilintide | 10%+ | Phase 3 | Not available | ₫3–5M | Stacking with GLP-1 |
Prices are approximate research-grade costs per month at maintenance doses. Hospital pricing for branded drugs (Mounjaro, Ozempic) is 2–3× higher.
Which one should you choose?
Want maximum weight loss → Retatrutide. The triple-agonist mechanism (GLP-1 + GIP + glucagon) makes retatrutide the most powerful weight loss peptide ever studied in clinical trials. The Phase 2 results showed 28.7% average body weight reduction over 48 weeks, which is substantially more than any dual-agonist or single-agonist compound. The glucagon agonism directly increases metabolic rate and fat oxidation, particularly visceral fat. The tradeoff: retatrutide has no FDA approval yet, so you're limited to the research-grade path. That means verifying supplier COAs, reconstituting powder yourself, and accepting you're using a compound still in Phase 3 trials. If you're comfortable with that and want the highest possible efficacy, read the retatrutide Vietnam 2026 guide for pricing, sourcing, and legal status.
Want proven safety and the lowest cost → Semaglutide. Semaglutide (Ozempic, Wegovy) has the longest track record of any GLP-1 peptide. The STEP clinical trials demonstrated 14.9% average weight loss over 68 weeks, and millions of people worldwide have used it since FDA approval in 2017 for diabetes and 2021 for obesity. The safety profile is well understood, the side effect management is documented, and the research-grade cost is the lowest of the four options — typically ₫1.5–2.5M per month compared to ₫4–6M for retatrutide. In Vietnam, you have both the pharmacy route (Ozempic pens appear intermittently at pharmacies in HCMC and Hanoi) and the research-grade route. If you want to minimize cost and stick with the most proven compound, start with the semaglutide Vietnam 2026 guide.
Want balance of efficacy and availability → Tirzepatide. Tirzepatide (Mounjaro, Zepbound) is the sweet spot for many people. It's a dual-agonist (GLP-1 + GIP) that demonstrated 22.5% average weight loss in the SURMOUNT trials — significantly more than semaglutide but not quite as high as retatrutide. The GIP agonism appears to reduce nausea compared to pure GLP-1 drugs, which makes tirzepatide easier to tolerate for some users. In Vietnam, Mounjaro is available at international hospitals like FV and Vinmec, though stock fluctuates and pricing is premium (expect ₫8–12M per month). Research-grade tirzepatide is ₫2.5–4M per month and widely available from peptide suppliers. If you want FDA-approved efficacy with better Vietnam availability than pure GLP-1 options, read the tirzepatide Vietnam 2026 guide.
The Four Options Explained
Retatrutide
Retatrutide is a triple-agonist peptide that activates GLP-1, GIP, and glucagon receptors simultaneously, creating the most powerful metabolic shift of any weight loss compound ever studied. Phase 2 clinical trials showed 28.7% average body weight reduction over 48 weeks at the 12mg dose, with some participants losing over 30% of their starting weight. In Vietnam, retatrutide isn't available at any pharmacy or hospital — it remains an investigational Phase 3 compound globally. Your only path is research-grade sourcing from peptide suppliers who ship to Vietnam with cold-chain logistics. Pricing typically runs ₫4–6M per month at maintenance doses. The retatrutide Vietnam 2026 guide covers supplier verification, COA red flags, reconstitution protocols, and what expats need to know about legal status. Retatrutide is for people who want maximum efficacy, are comfortable with investigational compounds, and can handle the research-grade sourcing process.
Tirzepatide
Tirzepatide is a dual-agonist peptide that activates both GLP-1 and GIP receptors, delivering substantially more weight loss than single-agonist compounds while maintaining FDA approval and a strong safety profile. The SURMOUNT clinical trials demonstrated 22.5% average weight loss over 72 weeks at the 15mg dose, positioning tirzepatide between semaglutide and retatrutide in terms of efficacy. The GIP agonism appears to reduce GLP-1-driven nausea, making tirzepatide better tolerated than pure GLP-1 drugs for many users. In Vietnam, branded Mounjaro is available at FV Hospital and Vinmec, though stock fluctuates and pricing is premium (₫8–12M per month including consultations). Research-grade tirzepatide is widely available from peptide suppliers at ₫2.5–4M per month. The tirzepatide Vietnam 2026 guide breaks down hospital availability, pharmacy routes, research-grade pricing, and the Mounjaro vs generic decision. Tirzepatide is the best choice for people who want FDA-approved efficacy with better availability than semaglutide.
Semaglutide
Semaglutide is a GLP-1 receptor agonist that sparked the global weight loss peptide revolution and remains the most widely used option worldwide. The STEP clinical trials demonstrated 14.9% average weight loss over 68 weeks at the 2.4mg dose, and the safety profile is the best understood of any GLP-1 drug thanks to years of real-world use. Semaglutide is FDA-approved under two brand names: Ozempic (diabetes indication, 0.5–2mg doses) and Wegovy (obesity indication, up to 2.4mg). In Vietnam, Ozempic appears intermittently at pharmacies in District 1 and District 7 in HCMC, and occasionally in Hanoi expat areas, though availability is unpredictable. Research-grade semaglutide is the most affordable GLP-1 option at ₫1.5–2.5M per month and is widely available from peptide suppliers. The semaglutide Vietnam 2026 guide covers Ozempic vs research-grade sourcing, pharmacy hunting strategies, and pricing breakdowns. Semaglutide is the best choice for people new to GLP-1 peptides, those prioritizing cost, or anyone who wants the longest safety track record.
Cagrilintide
Cagrilintide is an amylin analogue that works through a completely different mechanism than GLP-1 agonists, making it a strong candidate for stacking rather than standalone use. Amylin is a hormone co-secreted with insulin that slows gastric emptying and suppresses appetite via different brain pathways than GLP-1. Phase 2 trials of cagrilintide alone showed approximately 10% weight loss, but the real promise is in combination therapy — Novo Nordisk is currently testing cagrilintide + semaglutide combinations in Phase 3 trials with early data suggesting additive effects beyond either drug alone. In Vietnam, cagrilintide is not available at any pharmacy or hospital and remains investigational globally. Research-grade cagrilintide is available from select peptide suppliers at ₫3–5M per month, though fewer suppliers stock it compared to the GLP-1 options. Most Vietnam-based users who experiment with cagrilintide do so by stacking it with semaglutide or tirzepatide to break through weight loss plateaus or enhance satiety. Cagrilintide is for advanced users who have already run a GLP-1 cycle and want to experiment with combination therapy.
Where to source in Vietnam
There are three main routes for getting GLP-1 peptides in Vietnam, and which one makes sense depends on your priorities around cost, convenience, medical supervision, and compound selection. The international hospital route gives you branded drugs (Mounjaro, Ozempic) with full medical oversight, but you'll pay premium prices and your options are limited to whatever happens to be in stock. The pharmacy hunting route is hit-or-miss — Ozempic appears intermittently at pharmacies in District 1 and District 7 in HCMC and occasionally in Hanoi expat areas, but availability fluctuates wildly and you're still limited to branded semaglutide. The research-grade supplier route is where most informed expats and locals land because it offers the best combination of cost, reliability, and compound selection.
Research-grade peptide suppliers ship directly to Vietnam with cold-chain logistics, usually via DHL or FedEx with gel ice packs and temperature monitoring. You receive lyophilized (freeze-dried) powder that you reconstitute with bacteriostatic water before injecting. The key things to verify before ordering: third-party COA (certificate of analysis) showing purity and actual peptide content, proper cold-chain shipping with temperature monitoring, clear reconstitution instructions, and responsive customer service via WhatsApp or Zalo. The community-verified supplier list tracks which suppliers Vietnam-based users actually trust, with notes on COA quality, shipping reliability, and customer service responsiveness. The buying peptides in Vietnam guide walks through the full research-grade sourcing process step by step.
COA verification is critical because research-grade peptides vary wildly in quality. A proper COA comes from an independent third-party lab (not the supplier's in-house lab), shows HPLC purity testing with a clear chromatogram, lists actual peptide content in milligrams (not just percentages), and includes the specific batch number that matches your vial. Red flags include COAs with no batch numbers, suspiciously perfect 99%+ purity claims with no supporting chromatogram, or suppliers who refuse to provide COAs before purchase. The COA verification guide explains how to read HPLC chromatograms and spot fake certificates. For cold-chain shipping specifics and what to do if your peptides arrive warm, check the cold-chain logistics FAQ in the buying guide.
Get started
If you've decided which peptide makes sense for your situation, the next step is running the numbers on your expected timeline. The retatrutide weight loss calculator uses Phase 2 clinical trial data to project your weight loss trajectory based on your starting stats, and the same dosing principles apply to tirzepatide and semaglutide (just with lower overall percentages). Once you know your timeline, browse the community-verified supplier list to find suppliers with strong Vietnam track records. Look for COA transparency, cold-chain shipping with temperature monitoring, and active customer support via WhatsApp or Zalo. Start conservative with dosing, titrate slowly to manage side effects, and track your progress weekly.
Retatrutide Weight Loss Calculator
Enter your stats and get a personalized timeline based on Phase 2 clinical trial data